Takeda | 4502 - Cash And Equivalent


Takeda reported JPY460.98B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Astellas Pharma JPY 281.6B 93.23B Mar/2026
Chugai Pharma JPY 426.6B 29.83B Dec/2025
Daiichi Sankyo JPY 449.81B 92.35B Mar/2026
Eisai JPY 245.42B 56.22B Mar/2026
Kyowa Hakko Kirin JPY 218.77B 15.83B Dec/2025
M3 JPY 156.18B 22.33B Mar/2026
Otsuka Holdings JPY 534.64B 123.53B Dec/2025
Shionogi JPY 711.4B 477.53B Mar/2026
Sumitomo Dainippon JPY 44.31B 5.82B Mar/2026
Takeda JPY 460.98B 134.07B Jun/2026
Terumo JPY 280.49B 63.34B Mar/2026